Research programme: metabolic disorder therapeutics - 7TM Pharma/Dr. Reddy's Laboratories

Drug Profile

Research programme: metabolic disorder therapeutics - 7TM Pharma/Dr. Reddy's Laboratories

Latest Information Update: 06 Jul 2010

Price : $50

At a glance

  • Originator 7TM Pharma; Dr Reddys Laboratories
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Research Metabolic disorders

Most Recent Events

  • 06 Jul 2010 This programme is still in active development
  • 17 Mar 2008 Early research in Metabolic disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top